Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended 31st December 2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Indrayani Biotech Ltd has submitted a certificate under SEBI Regulation 74(5) for the quarter ended 31 December 2025. The certificate was issued by the company's Registrar and Transfer Agent (RTA), MUFG Intime India Private Limited. It confirms that share certificates received from depository participants for dematerialisation during October–December 2025 were properly processed, accepted or rejected, and that the underlying securities were listed on BSE (Scrip Code: 526445). The RTA also confirmed that physical certificates were mutilated and cancelled, and the depositories' names were substituted as registered owners in the company's register of members within the prescribed timelines. The letter was signed by Ramya Ravi, Company Secretary and Compliance Officer, on 5 January 2026.
This is a routine quarterly regulatory compliance filing with no material impact on the company's financials, operations, or share price. It is a standard housekeeping requirement and signals normal administrative functioning of share transfer and demat activities.